Lysosomes Contribute to Anomalous Pharmacokinetic Behavior of Melanocortin-4 Receptor Agonists

By Gong Yuping   Zhao Zhiyang   McConn Donavon   Beaudet Beth   Tallman Melanie   Speake Jason   Ignar Diane   Krise Jeffrey  

Pharmaceutical Research, Vol. 24, Iss. 6, 2007-06 ,pp. : 1138-1144

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the estrogenic potency of nonylphenol in non-occupationally exposed humans

By Muller S.   Schmid P.   Schlatter C.  

Environmental Toxicology and Pharmacology, Vol. 6, Iss. 1, 1998-08 ,pp. : 27-33

Elsevier

Access to resources Recommend Favorite

Recent advances in pharmacokinetic extrapolation from preclinical data to humans

By Ward Keith W  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 583-594

Informa Healthcare

Access to resources Recommend Favorite

Bayesian Analysis of a Physiologically Based Pharmacokinetic Model for Perchloroethylene in Humans

By Qiu Junshan   Chien Yeh-Chung   Bruckner James   Fisher Jeffery  

Journal of Toxicology and Environmental Health, Vol. 73, Iss. 1, 2010-01 ,pp. : 74-91

Taylor & Francis Ltd

Access to resources Recommend Favorite

Analysis of Methylmercury Disposition in Humans Utilizing A PBPK Model and Animal Pharmacokinetic Data

By Young John F.   Wosilait Walter D.   Luecke Richard H.  

Journal of Toxicology and Environmental Health, Vol. 63, Iss. 1, 2001-05 ,pp. : 19-52

Taylor & Francis Ltd

Access to resources Recommend Favorite